| 1 |
35339025 | Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies. | 2022 May |
6 |
| 2 |
33545678 | Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma. | 2021 Feb 5 |
2 |
| 3 |
33577917 | Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. | 2021 Mar 15 |
1 |
| 4 |
32606016 | Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma. | 2020 Sep |
2 |
| 5 |
32736668 | Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis. | 2020 Aug 27 |
3 |
| 6 |
30478448 | Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. | 2019 Mar |
16 |
| 7 |
30739792 | Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer. | 2019 Mar 19 |
6 |
| 8 |
28573908 | The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>. | 2018 Jan |
1 |
| 9 |
29086249 | Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma. | 2018 Jun |
4 |
| 10 |
29112301 | Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. | 2018 Jan |
5 |
| 11 |
29487714 | Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors. | 2018 Jan 30 |
1 |
| 12 |
29959920 | Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer. | 2018 Sep 18 |
3 |
| 13 |
30174840 | Genetic and pharmacological inhibition of eIF4E effectively targets esophageal cancer cells and augments 5-FU's efficacy. | 2018 Jul |
5 |
| 14 |
30454696 | Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivity. | 2018 Nov 30 |
6 |
| 15 |
27932243 | Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma. | 2017 Jan 22 |
12 |
| 16 |
27941882 | Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. | 2017 May 25 |
2 |
| 17 |
29049978 | Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy. | 2017 Dec |
5 |
| 18 |
26945967 | eIF4E-phosphorylation-mediated Sox2 upregulation promotes pancreatic tumor cell repopulation after irradiation. | 2016 May 28 |
1 |
| 19 |
27114554 | Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E. | 2016 May 10 |
2 |
| 20 |
27379616 | Repositioning of anti-viral drugs as therapy for cervical cancer. | 2016 Oct |
1 |
| 21 |
27501049 | Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI. | 2016 Sep |
2 |
| 22 |
25422161 | Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E. | 2015 Feb |
5 |
| 23 |
25425688 | A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E. | 2015 Jan |
1 |
| 24 |
25510279 | The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled. | 2015 Jan |
1 |
| 25 |
25608710 | Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis. | 2015 Mar 15 |
2 |
| 26 |
25738706 | Ribavirin as a tri-targeted antitumor repositioned drug. | 2015 May |
2 |
| 27 |
26317515 | Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia. | 2015 |
6 |
| 28 |
24870236 | The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. | 2014 Jul 3 |
1 |
| 29 |
25477336 | When will resistance be futile? | 2014 Dec 15 |
2 |
| 30 |
23471078 | Human inducible nitric oxide synthase (iNOS) expression depends on chromosome region maintenance 1 (CRM1)- and eukaryotic translation initiation factor 4E (elF4E)-mediated nucleocytoplasmic mRNA transport. | 2013 Apr 1 |
1 |
| 31 |
23583375 | Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate. | 2013 May 10 |
4 |
| 32 |
21796793 | mRNA export and cancer. | 2012 Jan-Feb |
2 |
| 33 |
22397984 | Translation initiation factor eIF4E is a target for tumor cell radiosensitization. | 2012 May 1 |
1 |
| 34 |
21415224 | Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer. | 2011 May 1 |
4 |
| 35 |
21455212 | Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. | 2011 Jul |
1 |
| 36 |
22129918 | Targeting the oncogene eIF4E in cancer: From the bench to clinical trials. | 2011 Dec 1 |
1 |
| 37 |
20629523 | Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? | 2010 Oct |
3 |
| 38 |
19433856 | Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. | 2009 Jul 9 |
4 |
| 39 |
20049173 | Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer. | 2009 |
3 |
| 40 |
18706892 | Ribavirin targets eIF4E dependent Akt survival signaling. | 2008 Oct 24 |
6 |
| 41 |
16131589 | The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro. | 2005 Oct |
3 |
| 42 |
16251386 | Further evidence that ribavirin interacts with eIF4E. | 2005 Dec |
3 |
| 43 |
15601771 | Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. | 2004 Dec 28 |
7 |